Celestica sells 9,677,419 shares at US$310 and the underwriters take 1,451,612 more

Celestica priced a treasury offering of 9,677,419 common shares at US$310.00 each on August 5, 2026, for gross proceeds of US$3.0 billion, with BofA Securities and Citigroup as joint lead bookrunners and TD Securities as bookrunner [1][2]. The underwriters exercised their option on a further 1,451,612 shares in full on August 6, and the company estimated net proceeds of about US$3.39 billion after underwriting costs, with closing set for on or about August 7 [3][2]. The stated use is working capital and capital expenditures, in addition to general corporate purposes [1].

The scale is easier to read against the share count: 114,982,086 shares were outstanding at July 22, 2026, and the first half of the year produced US$767.2 million of cash from operations against US$493.3 million of capital spending [4]. The company's chief executive described the demand outlook as the strongest in the company's history and said multi-year visibility continues to strengthen [1].

For a U.S. holder the offering is the clearest statement yet of what the next two years look like: capital spending ahead of the revenue it is meant to serve, funded by equity rather than by the cash the business generates. Whether that is prudence or appetite depends on the customer forecasts the company does not publish, which is why the three customer percentages in each 10-Q are the number to watch alongside the capex line [4].